The store will not work correctly when cookies are disabled.
8-methoxy-9-phenoxy-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline
ID: ALA4067398
PubChem CID: 137633236
Max Phase: Preclinical
Molecular Formula: C19H21NO2
Molecular Weight: 295.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc2c(cc1Oc1ccccc1)C1CCCN1CC2
Standard InChI: InChI=1S/C19H21NO2/c1-21-18-12-14-9-11-20-10-5-8-17(20)16(14)13-19(18)22-15-6-3-2-4-7-15/h2-4,6-7,12-13,17H,5,8-11H2,1H3
Standard InChI Key: ZNGIYFCATPLRNY-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
25.4606 -23.9076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1744 -23.4940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1716 -22.6672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4588 -22.2620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7484 -23.4945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7525 -22.6753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3359 -23.4874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0444 -23.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3399 -22.6683 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.0494 -22.2682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8828 -21.4695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0728 -21.3786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7374 -22.1210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8869 -23.9056 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8881 -24.7270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8819 -22.2560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.8788 -21.4347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5908 -21.0240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5881 -20.2035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8742 -19.7967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1616 -20.2124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1678 -21.0316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
5 8 1 0
6 10 1 0
9 7 1 0
7 8 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 9 1 0
2 14 1 0
14 15 1 0
3 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 295.38 | Molecular Weight (Monoisotopic): 295.1572 | AlogP: 4.18 | #Rotatable Bonds: 3 |
Polar Surface Area: 21.70 | Molecular Species: BASE | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.03 | CX LogP: 3.76 | CX LogD: 2.13 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.85 | Np Likeness Score: 0.13 |
References
1. Crestey F, Jensen AA, Soerensen C, Magnus CB, Andreasen JT, Peters GHJ, Kristensen JL.. (2018) Dual Nicotinic Acetylcholine Receptor α4β2 Antagonists/α7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts., 61 (4): [PMID:29384668] [10.1021/acs.jmedchem.7b01895] |